![Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay](https://www.precisionformedicine.com/hs-fs/hubfs/Colon%20cancer%20microscopic%20photography%2c%20magnification.jpg?width=396&height=224&name=Colon%20cancer%20microscopic%20photography%2c%20magnification.jpg)
Translational Research - Biomarkers - Assays
Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay
|
By analyzing up to 800 genes (770 standard and up to 30 customized target genes of interest), we can monitor checkpoint inhibitor status and profile the body’s immune response, determining hot/cold tumor status.
Precision specializes in using these and other custom panels to support oncology therapeutic development, as well as to monitor immune status to support development of autoimmune indication therapies.
Autoimmune: Phase 2b clinical study in atopic dermatitis
Oncology: Phase 1/2 clinical trial to determine method of action
Oncology: Phase 1/2 trial in solid tumors
Our ApoStream® services support preclinical and clinical research, including multi-site studies, conducted anywhere in the world.
Precision’s specialty lab scientists take a collaborative and consultative approach to projects and can provide recommendations on biomarker assay strategies and implementation. Services can be provided individually or as part of a comprehensive therapeutic development package including biomarker assays and clinical trials.
Read our blog to gain more insights and discover work that Precision has supported.
Translational Research - Biomarkers - Assays